Assessing agreement between multiple raters with missing rating information, applied to breast cancer tumour grading.

by Thomas R Fanshawe, Andrew G Lynch, Ian O Ellis, Andrew R Green, Rudolf Hanka
Published 2008-08-01

Liver Kinase B1—A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women

by Binafsha Manzoor Syed, Andrew R Green, David A L Morgan, Ian O Ellis, Kwok-Leung Cheung
Published 2019-01-01

Biology of Oestrogen-Receptor Positive Primary of Core Needle Biopsy Samples and Correlation with Clinical Outcome

by Ruth M. Parks, Mohammad Albanghali, Binafsha M. Syed, Andrew R. Green, Ian O. Ellis, Kwok-Leung Cheung
Published 2020-07-01

Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy

by Daria S. Chulpanova, Kristina V. Kitaeva, Andrew R. Green, Albert A. Rizvanov, Albert A. Rizvanov, Valeriya V. Solovyeva
Published 2020-06-01

Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome

by Binafsha M Syed, Andrew R Green, Emad A Rakha, David AL Morgan, Ian O Ellis, Kwok-Leung Cheung
Published 2021-03-01

XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib

by Reem Ali, Adel Alblihy, Michael S. Toss, Mashael Algethami, Rabab Al Sunni, Andrew R. Green, Emad A. Rakha, Srinivasan Madhusudan
Published 2020-12-01

Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.

by Binafsha Manzoor Syed, Dal Morgan, Tulassi Setty, Andrew R Green, Emma C Paish, Ian O Ellis, K L Cheung
Published 2018-01-01

Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.

by Binafsha Manzoor Syed, Dal Morgan, Tulassi Setty, Andrew R Green, Emma C Paish, Ian O Ellis, K L Cheung
Published 2017-01-01

Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.

by Binafsha M Syed, Andrew R Green, Christopher C Nolan, David A L Morgan, Ian O Ellis, Kwok-Leung Cheung
Published 2014-01-01

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

by Lutfi H. Alfarsi, Rokaya El Ansari, Madeleine L. Craze, Brendah K. Masisi, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-05-01

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

by Simon J. Johnston, Dena Ahmad, Mohammed A. Aleskandarany, Sasagu Kurozumi, Chris C. Nolan, Maria Diez-Rodriguez, Andrew R. Green, Emad A. Rakha
Published 2018-10-01

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

by Rokaya El Ansari, Madeleine L. Craze, Islam Miligy, Maria Diez-Rodriguez, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2018-03-01

Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer

by Lutfi H. Alfarsi, Rokaya El Ansari, Brendah K. Masisi, Ruth Parks, Omar J Mohammed, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-06-01

Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer

by Lutfi H. Alfarsi, Rokaya El-Ansari, Madeleine L. Craze, Brendah K. Masisi, Omar J. Mohammed, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-02-01

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer

by Brendah K. Masisi, Rokaya El Ansari, Lutfi Alfarsi, Madeleine L. Craze, Natasha Jewa, Andrew Oldfield, Hayley Cheung, Michael Toss, Emad A. Rakha, Andrew R. Green
Published 2021-08-01

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

by Tarek M. A. Abdel-Fatah, Reem Ali, Maaz Sadiq, Paul M. Moseley, Katia A. Mesquita, Graham Ball, Andrew R. Green, Emad A. Rakha, Stephen Y. T. Chan, Srinivasan Madhusudan
Published 2019-08-01

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma

by Chitra Joseph, Mansour A. Alsaleem, Michael S. Toss, Yousif A. Kariri, Maryam Althobiti, Sami Alsaeed, Abrar I. Aljohani, Pavan L. Narasimha, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha
Published 2021-12-01

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age

by Simon J. Johnston, Binafsha M. Syed, Ruth M. Parks, Cíntia J. Monteiro, Joseph A. Caruso, Andrew R. Green, Ian O. Ellis, Kelly K. Hunt, Cansu Karakas, Khandan Keyomarsi, Kwok-Leung Cheung
Published 2020-03-01

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective...

by Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro, Kartikeya Bhardwaj, Stacey E. P. Joosten, Takaaki Fujii, Ken Shirabe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha, Nigel P. Mongan, David M. Heery, Wilbert Zwart, Steffi Oesterreich, Simon J. Johnston
Published 2020-08-01

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

by Adrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A. Rakha, Andrew R. Green, Patricia G. Santamaria, Celine Mulder, Simone Lemeer, Joaquin Arribas, Aleix Prat, Teresa Puig, Eva Gonzalez-Suarez
Published 2021-03-01